Chemed Q3 2025 Earnings Preview
Source: SeekingAlpha
2025-10-27 17:35:51 ET
More on Chemed
- Chemed Corp: Genius Of The Model Lies In Its Corporate Strategy
- Chemed Corporation (CHE) Q2 2025 Earnings Call Transcript
- VITAS Healthcare, a Chemed subsidiary, appoints new CEO
- Chemed revises 2025 EPS guidance to $22–$22.30, signals no significant 2026 Medicare cap in Florida
- Seeking Alpha’s Quant Rating on Chemed
Read the full article on Seeking Alpha
For further details see:
Chemed Q3 2025 Earnings Preview
Chemed Corp
NASDAQ: CHE
CHE Trading
-0.71% G/L:
$401.445 Last:
145,077 Volume:
$403.70 Open:
CHE Latest News
March 12, 2026 12:00:00 pm
Chemed Corporation to Present at the Oppenheimer 36th Annual Healthcare Conference
CHE Stock Data
$6,431,677,666
13,693,944
1.88%
225
N/A
Healthcare Providers & Services
Healthcare
US
Cincinnati
